Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B

Authors Information
Article Notes and Dates
To Cite : Shoaei S D, Sali S, Karamipour M, Riahi E. Non-Invasive Histologic Markers of Liver Disease in Patients With Chronic Hepatitis B, Hepat Mon. 2014 ;14(2):e14228. doi: 10.5812/hepatmon.14228.
Copyright: Copyright © 2014, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
  • 1. Ma J, Jiang Y, Gong G. Evaluation of seven noninvasive models in staging liver fibrosis in patients with chronic hepatitis B virus infection. Eur J Gastroenterol Hepatol. 2013; 25(4): 428-34[DOI][PubMed]
  • 2. Merican I, Guan R, Amarapuka D, Alexander MJ, Chutaputti A, Chien RN, et al. Chronic hepatitis B virus infection in Asian countries. J Gastroenterol Hepatol. 2000; 15(12): 1356-61[PubMed]
  • 3. McClune AC, Tong MJ. Chronic Hepatitis B and Hepatocellular Carcinoma. Cl Liver Dis. 2010; 14(3): 461-76[DOI]
  • 4. Lai CL, Yuen MF. The Natural History and Treatment of Chronic Hepatitis B: A Critical Evaluation of Standard Treatment Criteria and End Points. Ann Internal Med. 2007; 147(1): 58-61[DOI][PubMed]
  • 5. Chen C, Yang HI, Su J, et al. RIsk of hepatocellular carcinoma across a biological gradient of serum hepatitis b virus dna level. JAMA. 2006; 295(1): 65-73[DOI][PubMed]
  • 6. Yuen MF, Yuan HJ, Wong DKH, Yuen JCH, Wong WM, Chan AOO, et al. Prognostic determinants for chronic hepatitis B in Asians: therapeutic implications. Gut. 2005; 54(11): 1610-4[DOI][PubMed]
  • 7. Jin W, Lin Z, Xin Y, Jiang X, Dong Q, Xuan S. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterol. 2012; 12: 14[DOI][PubMed]
  • 8. EASL Jury . . EASL International Consensus Conference on Hepatitis B. 13-14 September, 2002: Geneva, Switzerland. Consensus statement (short version). J Hepatol. 2003; 38(4): 533-40[PubMed]
  • 9. Lok AS, McMahon BJ, Practice Guidelines Committee , American Association for the Study of Liver Diseases . . Chronic hepatitis B. Hepatol. 2001; 34(6): 1225-41[DOI][PubMed]
  • 10. Piccinino F, Sagnelli E, Pasquale G, Giusti G, Battocchia A, Bernardi M, et al. Complications following percutaneous liver biopsy: A multicentre retrospective study on 68 276 biopsies. J Hepatol. 1986; 2(2): 165-73[DOI][PubMed]
  • 11. Rockey DC, Caldwell SH, Goodman ZD, Nelson RC, Smith AD, American Association for the Study of Liver Diseases . . Liver biopsy. Hepatol. 2009; 49(3): 1017-44[DOI][PubMed]
  • 12. Friedman LS. Controversies in liver biopsy: Who, where, when, how, why? Gastroenterol Rep. 2004; 6(1): 30-6[DOI][PubMed]
  • 13. Bedossa P, Dargere D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatol. 2003; 38(6): 1449-57[DOI][PubMed]
  • 14. Douds AC, Joseph AE, Finlayson C, Maxwell JD. Is day case liver biopsy underutilised? Gut. 1995; 37(4): 574-5[DOI][PubMed]
  • 15. Tseng PL, Wang JH, Hung CH, Tung HD, Chen TM, Huang WS, et al. Comparisons of noninvasive indices based on daily practice parameters for predicting liver cirrhosis in chronic hepatitis B and hepatitis C patients in hospital and community populations. Kaohsiung J Med. 2013; 29(7): 385-95[PubMed]
  • 16. Zhang YX, Wu WJ, Zhang YZ, Feng YL, Zhou XX, Pan Q. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World J Gastroenterol. 2008; 14(46): 7117-21
  • 17. Chrysanthos NV, Papatheodoridis GV, Savvas S, Kafiri G, Petraki K, Manesis EK, et al. Aspartate aminotransferase to platelet ratio index for fibrosis evaluation in chronic viral hepatitis. Europ J Gastroenterol Hepatol. 2006; 18(4): 389-96[PubMed]
  • 18. Seto WK, Lee CF, Lai CL, Ip PP, Fong DY, Fung J, et al. A new model using routinely available clinical parameters to predict significant liver fibrosis in chronic hepatitis B. PLoS One. 2011; 6(8)[DOI][PubMed]
  • 19. Zeng MD, Lu LG, Mao YM, Qiu DK, Li JQ, Wan MB, et al. Prediction of significant fibrosis in HBeAg-positive patients with chronic hepatitis B by a noninvasive model. Hepatol. 2005; 42(6): 1437-45[DOI][PubMed]
  • 20. Kim BK, Kim DY, Park JY, Ahn SH, Chon CY, Kim JK, et al. Validation of FIB-4 and comparison with other simple noninvasive indices for predicting liver fibrosis and cirrhosis in hepatitis B virus-infected patients. Liver Int. 2010; 30(4): 546-53[DOI][PubMed]
  • 21. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology. 1981; 1(5): 431-5[DOI][PubMed]
  • 22. Desmet VJ. Knodell RG, Ishak KG, Black WC, Chen TS, Craig R, Kaplowitz N, Kiernan TW, Wollman J. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis [Hepatology 1981;1:431-435]. J hepatol. 2003; 38(4): 382-6[PubMed]
  • 23. Ishak KG, Baptista A, Bianchi L, Callea F, De Groote J, Gudat F, et al. Histological grading and staging of chronic hepatitis. J hepatol. 1995; 22(6): 696-9
  • 24. Fung J, Lai CL, Fong DY, Yuen JC, Wong DK, Yuen MF. Correlation of liver biochemistry with liver stiffness in chronic hepatitis B and development of a predictive model for liver fibrosis. Liver International. 2008; 28(10): 1408-16[DOI][PubMed]
  • 25. Alavian SM, Alavian SH, Ashayeri N, Babaei M, Daneshbodi M, Hajibeigi B. Prediction of liver histological lesions with biochemical markers in chronic hepatitis B patients in Iran. Gastroenterol Hepatol. 2010; 3(2)
  • 26. Wai CT, Cheng CL, Wee A, Dan YY, Chan E, Chua W, et al. Non-invasive models for predicting histology in patients with chronic hepatitis B. Liver Int. 2006; 26(6): 666-72[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check